在一项新的试验中, AROA的Symphony皮肤替代品显示糖尿病足愈合率更高. AROA's Symphony skin substitute shows higher healing rates for diabetic foot ulcers in a new trial.

亚罗阿生物外科宣布完成其Symphony皮肤替代品的随机试验, 在治疗慢性糖尿病足方面取得初步成功. AROA Biosurgery announced the completion of a randomized trial for its Symphony skin substitute, showing preliminary success in treating chronic diabetic foot ulcers. 这项研究将Symphony与标准护理包裹进行比较,表明该产品导致伤口愈合率更高. The study compared Symphony to standard care dressings, indicating the product led to higher wound healing rates. 虽然最终结果尚未公布,但这些发现可能会加强临床采用并满足未来的补偿标准. While final results are pending, the findings could strengthen clinical adoption and meet future reimbursement standards.